(Q38164270)

30 August 2017

Congenital adrenal hyperplasia: issues in diagnosis and treatment in children (English)

1 reference

congenital adrenal hyperplasia

30 August 2017

0 references

1 reference

Rajni Sharma

1

1 reference

PubMed ID

24254335

30 August 2017

Anju Seth

series ordinal

2

1 reference

30 August 2017

20 November 2013

1 reference

Indian Journal of Pediatrics

30 August 2017

1 reference

30 August 2017

81

1 reference

30 August 2017

2

1 reference

30 August 2017

178-185

1 reference

https://scigraph.springernature.com/pub.10.1007/s12098-013-1280-8

30 August 2017

0 references

cites work

Congenital adrenal hyperplasia.

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Congenital adrenal hyperplasia: an Indian experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Newborn screening in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Male genitoplasty for 46 XX congenital adrenal hyperplasia patients presenting late and reared as males

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Genotyping Steroid 21-Hydroxylase Deficiency: Hormonal Reference Data*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Monitoring of therapy in congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Rapid second-tier molecular genetic analysis for congenital adrenal hyperplasia attributable to steroid 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Serum 17 alpha hydroxyprogesterone in normal full term and preterm vs sick preterm and full term newborns in a tertiary hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Prenatal treatment of congenital adrenal hyperplasia-not standard of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Pubertal development among girls with classical congenital adrenal hyperplasia initiated on treatment at different ages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Why is management of patients with classical congenital adrenal hyperplasia more difficult at puberty?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Congenital adrenal hyperplasia: a critical appraisal of the evolution of feminizing genitoplasty and the controversies surrounding gender reassignment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Sexual function and genital sensitivity following feminizing genitoplasty for congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

The role of bilateral adrenalectomy in the treatment of congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Final adult height in children with congenital adrenal hyperplasia treated with growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12098-013-1280-8

Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone

21 January 2018

1 reference

12 December 2020

Monitoring medical treatment in adolescents and young adults with congenital adrenal hyperplasia: utility of salivary 17α-hydroxyprogesterone day profiles

1 reference

12 December 2020

Molecular characterization of mutations in Indian children with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency

1 reference

12 December 2020

Neonatal screening for congenital adrenal hyperplasia

1 reference

12 December 2020

Long-term follow-up of female patients with congenital adrenal hyperplasia from 21-hydroxylase deficiency, with special emphasis on the results of vaginoplasty

1 reference

12 December 2020

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1 reference

12 December 2020

Congenital adrenal hyperplasia and the second newborn screen

1 reference

12 December 2020

Growth pattern and final height in 21-hydroxylase deficiency.

1 reference

12 December 2020

Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing

1 reference

12 December 2020

Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth

1 reference

12 December 2020

Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.

1 reference

12 December 2020

10.1007/S12098-013-1280-8

Identifiers

DOI

1 reference

PubMed ID

24254335

Dimensions Publication ID

30 August 2017

0 references

1 reference

PubMed ID

24254335